Effects of IASTM vs. Foam Rolling on Knee and Hip Range of Motion in Soccer Players

NCT ID: NCT06101615

Last Updated: 2023-10-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

10 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-08-15

Study Completion Date

2024-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is:

To compare the acute and long-term affects of instrument assisted soft tissue mobilization (IASTM) vs foam rolling on knee and hip flexibility and performance in soccer players.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The objective of this study is to compare the acute and long-term affects of instrument assisted soft tissue mobilization vs foam rolling on knee and hip flexibility and performance in soccer players. This is a randomized controlled trial, in which participants will be randomly divided into two groups: group-A and group-B. Group-A will receive intervention IASTM while Group-B will receive foam rolling as intervention. Intervention will be carried out for 8 weeks. Assessment of the range of motions for hip and knee joints will be carried out at baseline, immediately after the session, after four weeks and after five (5) months. The secondary measures of performance used in the study are sit and reach test, 100m sprint speed test, Illinois agility run test.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Muscle Tightness

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Concurrent Parallel Randomized Clinical Trial
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group A

IASTM Group

Group Type ACTIVE_COMPARATOR

IASTM (FAT)

Intervention Type OTHER

Group-A participants would receive Facial Abrasion Technique (FAT) with an Instrument, FAT-Tool. Treatment sessions will be carried out three times per week for eight weeks after an initial warm-up session. All the sessions will be performed at the same time of day (i.e., between 4-6 pm), to avoid possible confounding circadian effects. The FAT group will receive 2 min application on the quadriceps and hamstring muscles with a FAT-tool Pro Large model, which consists of a handle and 20cm treatment surface. The muscles will be treated in a pre-stretched position, meaning a knee flexion in a supine position for the quadriceps muscle and a hip flexion and knee extension in a side-lying position for the hamstring muscles.

Group B

Foam Rolling Group

Group Type ACTIVE_COMPARATOR

Foam Rolling

Intervention Type OTHER

Group-B participants would receive Foam Rolling (FR). Treatment sessions will be carried out three times per week for eight weeks after an initial warm-up session. All the sessions will be performed at the same time of day (i.e., between 4-6 pm) to avoid possible confounding circadian effects. The Foam Roller group will receive 2x1 min of FR on the quadriceps and the hamstrings on the dominant leg with the opposite leg crossed over the dominant one. During each minute the muscle will be rolled out 4-5 times, with a break of 30s in between sets. They will be instructed to utilize short, kneading like movements in one direction and a quick motion in the other direction. A grid foam roller will be utilized with a length of 33cm, diameter of 14 cm and with a hard hollow core, wrapped in ethylene vinyl acetate foam.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

IASTM (FAT)

Group-A participants would receive Facial Abrasion Technique (FAT) with an Instrument, FAT-Tool. Treatment sessions will be carried out three times per week for eight weeks after an initial warm-up session. All the sessions will be performed at the same time of day (i.e., between 4-6 pm), to avoid possible confounding circadian effects. The FAT group will receive 2 min application on the quadriceps and hamstring muscles with a FAT-tool Pro Large model, which consists of a handle and 20cm treatment surface. The muscles will be treated in a pre-stretched position, meaning a knee flexion in a supine position for the quadriceps muscle and a hip flexion and knee extension in a side-lying position for the hamstring muscles.

Intervention Type OTHER

Foam Rolling

Group-B participants would receive Foam Rolling (FR). Treatment sessions will be carried out three times per week for eight weeks after an initial warm-up session. All the sessions will be performed at the same time of day (i.e., between 4-6 pm) to avoid possible confounding circadian effects. The Foam Roller group will receive 2x1 min of FR on the quadriceps and the hamstrings on the dominant leg with the opposite leg crossed over the dominant one. During each minute the muscle will be rolled out 4-5 times, with a break of 30s in between sets. They will be instructed to utilize short, kneading like movements in one direction and a quick motion in the other direction. A grid foam roller will be utilized with a length of 33cm, diameter of 14 cm and with a hard hollow core, wrapped in ethylene vinyl acetate foam.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Individuals with normal BMI
* Players with at least one year of playing professional soccer and taking at least three training sessions/matches per week.

Exclusion Criteria

* Players with any pathological conditions affecting any of the system.
* Suffering from recent acute unhealed MSK injury/Trauma.
Minimum Eligible Age

18 Years

Maximum Eligible Age

35 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Riphah International University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Noman Sadiq, MS-SPT

Role: PRINCIPAL_INVESTIGATOR

Riphah International University, Islamabad.

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Riphah International University (RIU)

Islamabad, Islamabad, Pakistan

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Pakistan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Noman Sadiq, MS-SPT

Role: CONTACT

+923145520548

Mansoor Kh Achakzai, MS-SPT*

Role: CONTACT

+923333821556

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Noman Sadiq, MS-SPT

Role: primary

+923145520548

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

REC/01616 Mansoor Kh Achakzai

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.